Search

Leigh C. Maier

Examiner (ID: 4240, Phone: (571)272-0656 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1673, 1693, 1614, 1623, 1621
Total Applications
1395
Issued Applications
727
Pending Applications
80
Abandoned Applications
594

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16954870 [patent_doc_number] => 11058697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Inhibiting inflammation with milk oligosaccharides [patent_app_type] => utility [patent_app_number] => 15/998799 [patent_app_country] => US [patent_app_date] => 2018-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3303 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15998799 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/998799
Inhibiting inflammation with milk oligosaccharides Aug 15, 2018 Issued
Array ( [id] => 14069119 [patent_doc_number] => 20190083447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER [patent_app_type] => utility [patent_app_number] => 16/055935 [patent_app_country] => US [patent_app_date] => 2018-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16055935 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/055935
REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER Aug 5, 2018 Abandoned
Array ( [id] => 16341652 [patent_doc_number] => 20200306302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => TREATING AND INHIBITING LEUKEMIA WITH NK-92 CELLS [patent_app_type] => utility [patent_app_number] => 16/636266 [patent_app_country] => US [patent_app_date] => 2018-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10953 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636266 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/636266
TREATING AND INHIBITING LEUKEMIA WITH NK-92 CELLS Aug 2, 2018 Abandoned
Array ( [id] => 19593229 [patent_doc_number] => 12151047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-26 [patent_title] => Hydrogel for tissue engineering and bioprinting [patent_app_type] => utility [patent_app_number] => 16/641056 [patent_app_country] => US [patent_app_date] => 2018-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 30 [patent_no_of_words] => 11714 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641056 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/641056
Hydrogel for tissue engineering and bioprinting Jul 24, 2018 Issued
Array ( [id] => 13549141 [patent_doc_number] => 20180326118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => IMMOBILISED BIOLOGICAL ENTITIES [patent_app_type] => utility [patent_app_number] => 16/042945 [patent_app_country] => US [patent_app_date] => 2018-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042945 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/042945
IMMOBILISED BIOLOGICAL ENTITIES Jul 22, 2018 Abandoned
Array ( [id] => 13823917 [patent_doc_number] => 20190015443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH 2-O AND, OR 3-O DESULFATED HEPARINOIDS [patent_app_type] => utility [patent_app_number] => 16/041444 [patent_app_country] => US [patent_app_date] => 2018-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041444 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/041444
TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH 2-O AND, OR 3-O DESULFATED HEPARINOIDS Jul 19, 2018 Abandoned
Array ( [id] => 16596570 [patent_doc_number] => 20210023101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => POTENTIATION OF ANTIBIOTIC EFFECT [patent_app_type] => utility [patent_app_number] => 16/630174 [patent_app_country] => US [patent_app_date] => 2018-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13001 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630174 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630174
POTENTIATION OF ANTIBIOTIC EFFECT Jul 18, 2018 Abandoned
Array ( [id] => 13533583 [patent_doc_number] => 20180318334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => DRUG CONTAINING CATIONIZED CHITOSAN [patent_app_type] => utility [patent_app_number] => 16/034710 [patent_app_country] => US [patent_app_date] => 2018-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034710 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/034710
DRUG CONTAINING CATIONIZED CHITOSAN Jul 12, 2018 Abandoned
Array ( [id] => 16252119 [patent_doc_number] => 20200261493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => FUCOSYLATED CHONDROITIN SULFATE OLIGOSACCHARIDE AND METHOD FOR RAPIDLY PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 16/762147 [patent_app_country] => US [patent_app_date] => 2018-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7336 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762147 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/762147
Mixture of fucosylated chondroitin sulfate oligosaccharides and method for rapidly producing the same Jul 10, 2018 Issued
Array ( [id] => 13522139 [patent_doc_number] => 20180312612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => METHOD FOR PREPARING SUGAMMADEX SODIUM [patent_app_type] => utility [patent_app_number] => 16/031083 [patent_app_country] => US [patent_app_date] => 2018-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031083 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/031083
METHOD FOR PREPARING SUGAMMADEX SODIUM Jul 9, 2018 Abandoned
Array ( [id] => 13778111 [patent_doc_number] => 20190002594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => Chitosan-Derived Compositions [patent_app_type] => utility [patent_app_number] => 16/028160 [patent_app_country] => US [patent_app_date] => 2018-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18143 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028160 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/028160
Chitosan-Derived Compositions Jul 4, 2018 Abandoned
Array ( [id] => 16398848 [patent_doc_number] => 20200339706 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-10-29 [patent_title] => Chitosan-Derived Compositions [patent_app_type] => utility [patent_app_number] => 16/028221 [patent_app_country] => US [patent_app_date] => 2018-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20144 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028221 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/028221
Chitosan-derived compositions Jul 4, 2018 Issued
Array ( [id] => 16398848 [patent_doc_number] => 20200339706 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2020-10-29 [patent_title] => Chitosan-Derived Compositions [patent_app_type] => utility [patent_app_number] => 16/028221 [patent_app_country] => US [patent_app_date] => 2018-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20144 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028221 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/028221
Chitosan-derived compositions Jul 4, 2018 Issued
Array ( [id] => 14403579 [patent_doc_number] => 20190167633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY [patent_app_type] => utility [patent_app_number] => 16/026886 [patent_app_country] => US [patent_app_date] => 2018-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16026886 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/026886
COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY Jul 2, 2018 Abandoned
Array ( [id] => 13493149 [patent_doc_number] => 20180298117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => Heparan Sulfate Having High 3-O-Sulfation Rate in Glucosamine Residues [patent_app_type] => utility [patent_app_number] => 16/018487 [patent_app_country] => US [patent_app_date] => 2018-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16018487 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/018487
Heparan sulfate having high 3-O-sulfation rate in glucosamine residues Jun 25, 2018 Issued
Array ( [id] => 16786086 [patent_doc_number] => 10988498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs [patent_app_type] => utility [patent_app_number] => 16/011055 [patent_app_country] => US [patent_app_date] => 2018-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27475 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011055 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/011055
Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs Jun 17, 2018 Issued
Array ( [id] => 18526374 [patent_doc_number] => 11713360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Method for producing cellulose nanofibers [patent_app_type] => utility [patent_app_number] => 16/607870 [patent_app_country] => US [patent_app_date] => 2018-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4386 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607870 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/607870
Method for producing cellulose nanofibers May 31, 2018 Issued
Array ( [id] => 13424957 [patent_doc_number] => 20180264021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN [patent_app_type] => utility [patent_app_number] => 15/988368 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11135 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988368 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/988368
Treatment of papulopustular rosacea with ivermectin May 23, 2018 Issued
Array ( [id] => 15646649 [patent_doc_number] => 20200085854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => COMPOSITION FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL GASTRIC REFLUX SYMPTOMS [patent_app_type] => utility [patent_app_number] => 16/617368 [patent_app_country] => US [patent_app_date] => 2018-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617368 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/617368
COMPOSITION FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL GASTRIC REFLUX SYMPTOMS May 17, 2018 Abandoned
Array ( [id] => 13548787 [patent_doc_number] => 20180325941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT [patent_app_type] => utility [patent_app_number] => 15/977840 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9364 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977840 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/977840
COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT May 10, 2018 Abandoned
Menu